Status:
COMPLETED
Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
Lead Sponsor:
Novexel Inc
Conditions:
Community Acquired Pneumonia
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the efficacy, safety and tolerance of 2 different dose levels of oral NXL103 with oral comparator in the treatment of community acquired pneumonia in adults
Eligibility Criteria
Inclusion
- Community acquired pneumonia
Exclusion
- severe CAP
- respiratory infections attributed to sources other than community acquired bacterial infection
- concomitant pulmonary disease
- history of hypersensitivity to study medication, macrolide or beta lactam antibiotics
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT00653172
Start Date
October 1 2007
End Date
November 1 2008
Last Update
January 9 2009
Active Locations (60)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica de Enfermedades Resp. "Miguel de Servet" SA
Santiago, Chile
2
Complejo Asistencial Barros Luco Trudeau
Santiago, Chile
3
Hospital de Urgencia Asistencia Publica
Santiago, Chile
4
Hospital Regional de Rancagua
Santiago, Chile